-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The new coronary pneumonia caused by the new coronavirus is a viral infection.
Cellular immunity plays an important role in resisting the progression of the disease.
Therefore, identifying and amplifying the specific cellular immune response to SARS-CoV-2 is to enhance and improve patients with new coronavirus The key to clinical results
.
Previous studies have shown that after 10 months of infection with the new coronavirus, SARS-CoV-2 specific T cells still exist in the peripheral blood
The new coronary pneumonia caused by the new coronavirus is a viral infection.
The researchers collected patients in a prospective cohort study within 12 months after SARS-CoV-2 infection.
These patients represented a range of different phenotypes of disease severity
.
Then use intracellular cytokine staining and spectral flow cytometry to study the function, phenotype and proportion of SARS-CoV-2 specific T cells
The results of the study showed that SARS-CoV-2 specific antibodies and specific T cells were still detected 12 months after infection
.
The severity of the acute disease is related to the higher frequency of SARS-CoV-2 specific CD4T-positive cells and antibodies at 12 months
This study confirmed that SARS-CoV-2 infection can still induce detectable multifunctional memory T cells 12 months after infection.
This phenomenon occurs more frequently in people who initially suffer from serious diseases
.
This phenomenon occurs more frequently in people who initially suffer from serious diseases
.
Original source:
Zhongyan Lu.
Leave a message here